Related Experiment Video
Updated: Apr 15, 2026
07:43
Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
Published on: May 3, 2024
4.8K
Identification of biomarkers for metastatic osteosarcoma based on DNA microarray data.
Neoplasma
|April 14, 2015
Summary
This study identifies key genes involved in osteosarcoma pulmonary metastasis. Several genes, including BAI2 and FMNL1, show potential as biomarkers for predicting metastasis and as therapeutic targets in osteosarcoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Osteosarcoma (OS) is a primary bone malignancy with high mortality, largely due to pulmonary metastasis.
- Identifying biomarkers for metastatic OS is crucial for understanding metastasis mechanisms and developing targeted therapies.
Purpose of the Study:
- To screen for potential biomarkers associated with pulmonary metastasis in osteosarcoma.
- To explore the molecular mechanisms underlying OS pulmonary metastasis using network construction.
Main Methods:
- Downloaded and analyzed Gene Expression Omnibus dataset GSE14359, comparing conventional OS and OS with pulmonary metastasis.
- Identified differentially expressed genes (DEGs) using R limma packages and t-tests (FDR < 0.05).
- Performed functional annotation using DAVID (FDR < 0.01) and constructed a differential coexpression network using SDC analysis.
Main Results:
- Identified 1344 DEGs (677 upregulated, 667 downregulated) in pulmonary metastatic OS.
- Discovered 31 significantly enriched functions, including blood vessel morphogenesis and cell death.
- Identified high-degree genes in the differential coexpression network: BAI2, FMNL1, DUSP7, TRPM2, KIAA0427, and C120rf35.
Conclusions:
- Genes such as BAI2, FMNL1, DUSP7, and TRPM2 are potential biomarkers for predicting osteosarcoma metastasis.
- These identified genes represent promising therapeutic targets for treating metastatic osteosarcoma.
